Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Lengo Therapeutics presents new EGFR and HER2 inhibitors

May 27, 2022

Athira Pharma discloses new HGFR modulators

May 27, 2022

Eternity Bioscience patents new Raf kinase inhibitors

May 27, 2022

U.S. researchers present new NR1D2 agonists

May 26, 2022

New EGFR inhibitors identified at Lengo Therapeutics

May 26, 2022

Rhizen Pharmaceuticals divulges new PARP inhibitors

May 26, 2022

Newave Pharmaceutical discloses new BTK inhibitors

May 26, 2022

Integral BioSciences patents ENPP1 inhibitors

May 26, 2022

In4Derm Limited presents new BRD4 BD2 inhibitors

May 25, 2022

Chinese researchers identify HSP90A inhibitors

May 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...